当前位置:首页 > 股票大全 > 安图生物 603658 财务分析

安图生物财务分析

整理编辑：168股票行情网：www.gphq168.com    数据来源：互联网 经供参考

安图生物(603658)利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入1,089,195,256.054,443,655,727.693,242,497,407.542,107,941,206.59
营业总成本777,943,233.443,214,959,512.362,326,702,156.561,556,340,161.47
营业利润363,984,360.141,365,747,952.771,006,478,551.7605,966,654.41
利润总额361,812,462.621,362,543,913.161,006,723,328.21608,705,140.73
净利润328,699,468.291,224,130,688.66915,410,745.17555,301,480.13
其他综合收益13,321.47424,846.11587,541.93615,993.25
综合收益总额328,712,789.761,224,555,534.77915,998,287.1555,917,473.38
安图生物(603658)资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计6,618,533,445.666,613,020,601.816,380,528,230.46,089,546,219.76
非流动资产合计4,987,389,203.154,941,037,667.564,691,691,677.994,490,658,031.59
资产总计11,605,922,648.8111,554,058,269.3711,072,219,908.3910,580,204,251.35
流动负债合计2,056,935,298.222,483,163,318.262,271,767,026.042,142,334,078.09
非流动负债合计695,128,374.44404,563,613.23442,493,351.31439,991,455.97
负债合计2,752,063,672.662,887,726,931.492,714,260,377.352,582,325,534.06
归属于母公司股东权益合计8,779,841,632.448,535,461,518.038,219,291,153.067,864,272,240.41
股东权益合计8,853,858,976.158,666,331,337.888,357,959,531.047,997,878,717.29
负债和股东权益合计11,605,922,648.8111,554,058,269.3711,072,219,908.3910,580,204,251.35
安图生物(603658)现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计1,332,115,082.484,935,953,837.913,608,645,364.912,377,463,833.9
经营活动现金流出小计1,003,712,960.213,466,097,973.692,657,532,339.51,841,019,429.12
经营活动产生的现金流量净额328,402,122.271,469,855,864.22951,113,025.41536,444,404.78
投资活动现金流入小计240,439,596.823,540,443,231.31142,455,317.92104,489,611.49
投资活动现金流出小计863,422,477.714,327,664,692.441,599,897,102.581,048,429,584.7
投资活动产生的现金流量净额-622,982,880.89-787,221,461.13-1,457,441,784.66-943,939,973.21
筹资活动现金流入小计579,182,222.241,165,079,781.81,012,000,000765,000,000
筹资活动现金流出小计692,370,390.961,502,092,279.151,203,706,034.071,026,961,512.8
筹资活动产生的现金流量净额-113,188,168.72-337,012,497.35-191,706,034.07-261,961,512.8
汇率变动对现金及现金等价物的影响-170,320.353,146,135.183,478,675.263,457,292.92
现金及现金等价物净增加额-407,939,247.69348,768,040.92-694,556,118.06-665,999,788.31
期末现金及现金等价物余额1,077,430,057.761,485,369,305.45442,045,146.47470,601,476.22
安图生物603658相关数据
今日股市大盘指数